Weekly Insider Money Tracking: Directors of Cerevel Therapeutics Buy Close to $400 Million Worth of Stock

Last week, the major shareholder of $Cerevel Therapeutics Holdings (CERE.US)$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at the same price. Moreover, with PERCEPTIVE ADVISORS purchasing additional shares valued at $20 million, insiders at Cerevel Therapeutics made total purchases of $395 million.